These nanoparticles created by MIT engineers can act as synthetic biomarkers for disease. The particles (brown) are coated with peptides (blue) that are cleaved by enzymes (green) found at the disease site. The peptides then accumulate in the urine, where they can be detected using mass spectrometry. Image: Justin H. Lo
Study illuminates role of cancer drug decitabine in repairing damaged cells A Purdue University study sheds light on how cell damage is reversed by the cancer drug decitabine and identifies a potential biomarker that could indicate a patient's stage of cancer and response to treatment.
RFID Implants Found to Cause Cancer Tumors linked to cancer in laboratory animals, research reviewed by Associated Press. The evidence is strong enough to convince many researchers that more research is needed before any more human implantation takes place.
Laboratory-on-a-chip technique simplifies detection of cancer DNA biomarkers http://internetmedicine.com/2016/12/14/53914/ SOURCE December 2016 (Nanowerk News) Cancer is the second leading cause of death in the U.S. making early reliable diagnosis and treatment a priority for researchers. Genomic biomarkers offer great potential for diagnostics and new forms of treatment such as immunotherapy. Miniaturized lab-on-chip approaches are prime candidates for developing viable diagnostic tests…
Tshililo Michael Masutha, South Africa’s deputy minister of science and technology, participates in cutting the ribbon during the opening ceremony of the Cape Town HVTN Immunology Laboratory on Oct. 23, 2013 in Cape Town, South Africa. Photo by Robert Hood, Fred Hutchinson Cancer Research Center.